Explore
← New search
Filters:
PT
✕
Oncode Institute
✕
somatic mutation/snv/cna/structural variant sequencing analysis
✕
clear all
1 matching publication(s)
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
PMID 36450752 · Nat Commun · 2022
L1
70/100